Virazole study
Executive Summary
ICN and its Viratek and SPI Pharmaceutical subsidiaries have signed a 15-year agreement with the U.S. Army Medical Research & Development Command for "cooperative study of the antiviral drug" ribavirin, according to a June 18 announcement. The Army has agreed to file "one or more NDAs for intravenous and oral" ribavirin within nine and 24 months, respectively.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.